MiNK Therapeutics, Inc. (INKT)

11.90 +0.45 (+3.93%) USD  |  NASDAQ  |  Sep 09, 15:48
More

MiNK Therapeutics Beta (5Y)

Beta (5Y) Chart

View Beta (5Y) for INKT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Beta (5Y) Chart
Start Trial

Historical Beta (5Y) Data

View and export this data back to . Start Trial.
Date Value

Beta Definition

Beta is a risk metric that measures the risk associated with a security in comparison to the risk associated with the market overall. A beta of 1 would signify that the beta is neutral with the market. A common use of beta is within the Capital Asset Pricing Model (CAPM), to find a security's expected return.

Read full definition.

Beta (5Y) Range, Past 5 Years

View Beta (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Beta (5Y) Benchmarks

View Beta (5Y) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade